All contributors
Onconephrology contributor
Hayman, Suzanne R
Primarily MGRS & paraprotein kidney disease#29 of 47 recognizedHonor roll
47
Clinical papers
2,241
Citations (iCite)
2 / 2
First / senior author
2005–2026
Active years
Output over time
Clinical corpus papers per year — peak 6 in 2020.
- 2005: 2 papers
- 2007: 3 papers
- 2008: 1 paper
- 2009: 1 paper
- 2010: 2 papers
- 2011: 1 paper
- 2012: 4 papers
- 2013: 2 papers
- 2014: 1 paper
- 2015: 1 paper
- 2016: 3 papers
- 2017: 2 papers
- 2018: 3 papers
- 2019: 2 papers
- 2020: 6 papers
- 2021: 1 paper
- 2022: 3 papers
- 2023: 3 papers
- 2024: 2 papers
- 2025: 3 papers
- 2026: 1 paper
20052026
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
MGRS & paraprotein kidney disease34
Myeloma cast nephropathy26
Anti-VEGF / TKI renal effects2
Anticancer drug nephrotoxicity1
Tumor lysis & electrolytes1
Cellular therapy renal effects1
Frequent collaborators
Other recognized contributors who most often share corpus papers with Hayman (shared-paper count).
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.